There's not any one specific factor that we know of, or that has been studied, to say, These are the patients who are being extremely successful at maintaining weight loss versus not being successful, says Simonetti
Reasonable endocrinologists and orthopedic specialists interpret the current findings with appropriate uncertainty - and with appropriate urgency about building a protection plan from the start of GLP-1 therapy
Prevalence & Significance of Folate Deficiency More than 1 in 3 people struggle to use folate and folic acid due to genetic changes, like in the MTHFR gene, which prevent the body from turning folate into its active form (5-MTHF)
Retatrutide Regulatory Status in Canada Investigational Drug Status Retatrutide is not an authorized health product in Canada and does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada
The rationale is that GLP-1 agonists can reduce B12 absorption over time, and supplementing directly in the injection addresses this proactively
